Skip to content

Form 4 filed by RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P. filed this Form 4 on Bambusa Therapeutics, Inc. with 10 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 23:09:57 UTC.

Accession
0001231919-26-001533
Filed
2026-11-03
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Bambusa Therapeutics, Inc. (CIK 2044950)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-10-30P bought+189,909$14.23189,909I See footnotes
Common Stock 2026-10-30P bought+263,911$14.92453,820I See footnotes
Common Stock 2026-11-02C converted+3,144,8583,598,678I See footnotes
Common Stock 2026-11-02C converted+1,331,0801,331,080I See footnotes
Common Stock 2026-11-02P bought+2,335,109$165,933,787I See footnotes
Common Stock 2026-11-02P bought+164,891$161,495,971I See footnotes
Series A-1 Preferred Stock derivative2026-11-02C converted-2,844,910$00I See footnotes
Series A-1 Preferred Stock derivative2026-11-02C converted-1,278,148$00I See footnotes
Series A-2 Preferred Stock derivative2026-11-02C converted-299,948$00I See footnotes
Series A-2 Preferred Stock derivative2026-11-02C converted-52,932$00I See footnotes